Skip to main content

TriSalus Life Sciences, Inc.

TLSIW
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001826667

No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.

Other share classesTLSI

13F holders, Q2 2024

Institutional positions in TriSalus Life Sciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
19
−3 vs. Q1 2024
Shares held
2.16M
−428.9K (−16.6%) vs. Q1 2024
Total value
$3.71M
+$375.6K (+11.3%) vs. Q1 2024
New holders
2
1 more added
Sold out
5
5 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TLSIW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 19 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 20 institutionsQ4 2023: 23 institutionsQ1 2024: 22 institutionsQ2 2024: 19 institutionsQ3 2024: 8 institutionsQ4 2024: 8 institutionsQ1 2025: 6 institutionsQ2 2025: 5 institutionsQ3 2025: 4 institutionsQ4 2025: 8 institutionsQ1 2026: 7 institutionsQ2 2026: 5 institutions
Value heldQ2 2024: $3.71M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $1.20MQ4 2023: $3.72MQ1 2024: $3.33MQ2 2024: $3.71MQ3 2024: $208.0KQ4 2024: $1.08MQ1 2025: $1.11MQ2 2025: $1.25MQ3 2025: $337.4KQ4 2025: $1.77MQ1 2026: $1.23MQ2 2026: $798.0K
Institutions holding TLSIW and their total value by quarter
QuarterHoldersValue
Q2 20265$798.0K
Q1 20267$1.23M
Q4 20258$1.77M
Q3 20254$337.4K
Q2 20255$1.25M
Q1 20256$1.11M
Q4 20248$1.08M
Q3 20248$208.0K
Q2 202419$3.71M
Q1 202422$3.33M
Q4 202323$3.72M
Q3 202320$1.20M
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding TriSalus Life Sciences, Inc.; share changes are against Q1 2024.

Institutions holding TLSIW in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Magnetar Financial LLC642,163$1.17M0.02%−125,000−16.3%Reduced
Deerfield Management Company, L.P. (Series C)333,333$543.3K0.01%00.0%Unchanged
Polar Asset Management Partners Inc.259,262$430.4K0.01%−26,602−9.3%Reduced
Vestcor Inc148,755$242.0K0.01%00.0%Unchanged
MSD Partners, L.P.133,333$217.3K0.02%00.0%Unchanged
Bluefin Capital Management, LLC115,989$211.1K0.06%+115,989New
Bracebridge Capital, LLC92,880$151.4K0.08%00.0%Unchanged
Walleye Capital LLC80,883$147.2K0.00%00.0%Unchanged
Cable Car Capital LLC76,287$124.3K0.13%+76,287New
Sequoia Financial Advisors, LLC62,187$103.2K0.00%00.0%Unchanged
CastleKnight Management LP46,371$84.4K0.01%00.0%Unchanged
Walleye Trading LLC45,496$82.8K0.00%00.0%Unchanged
HRT Financial LP29,931$54.0K0.00%−25−0.1%Reduced
Kim, LLC19,007$34.6K0.00%−60,000−75.9%Reduced
B & T Capital Management DBA Alpha Capital Management22,222$33.3K0.01%00.0%Unchanged
Cowen and Company, LLC20,369$33.2K0.00%−30,055−59.6%Reduced
Foster Victor Wealth Advisors, LLC21,158$27.1K0.00%+185+0.9%Added
Nomura Holdings Inc10,800$19.7K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)42$700.00%00.0%Unchanged
Highbridge Capital Management LLC0$00.00%–Sold out
Exos Asset Management LLC0$00.00%−167,610−100.0%Sold out
Wolverine Asset Management LLC0$00.00%−117,290−100.0%Sold out
Aristeia Capital LLC0$00.00%−53,561−100.0%Sold out
Clear Street LLC0$00.00%−41,169−100.0%Sold out